NLRP3 and neoplasm: In addition, luteolin treatment (50 mg/kg/day i.p. injected) increased ASC, cleaved caspase-1, IL-1β, and NLRP3 protein levels in xenografts of HT-29 cells in nude mice, simultaneously decreasing tumor size [216].